Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism
Yıl: 2022 Cilt: 60 Sayı: 2 Sayfa Aralığı: 145 - 151 Metin Dili: İngilizce DOI: 10.4274/haseki.galenos.2022.7783 İndeks Tarihi: 21-06-2022
Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism
Öz: Aim: Pulmonary embolism (PE) is a condition caused by thrombosis and is a common cause of death. Although there are studies of
PE with CHA2DS2-VASc (C: congestive heart failure or left ventricular systolic dysfunction, H: hypertension, A: age of ≥75 years, D:
diabetes mellitus, S: previous stroke, V: vascular disease, A: age between 65 and 74 years, Sc: female gender) and PE severity index
(PESI) scores, there is no data on Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) score in PE or comparison of CHA2DS2-
VASc and ATRIA scores in PE. We investigated whether ATRIA and CHA2DS2-VASc scores can predict PE and mortality in cases of PE.
Methods: One hundred ninety-eight patients with PE and two hundred eighty controls between July 2017 and July 2021 were included
in this retrospective study. Patients’ data was provided from the hospital’s digital system. Patients’ PESI, ATRIA, and CHA2DS2-VASc
scores were calculated, and in-hospital mortality was determined as the primary end-point.
Results: The mean age of the patients was 63.9±13.1 years. The frequency of male patients in the PE group was higher (p=0.04), but
this difference was invalid in patients with PE who developed primary end-point (p=0.177). ATRIA and CHA2DS2-VASc scores were
higher in the PE group (p<0.01 and p=0.02, respectively) and in patients who reached end-point (p=0.001 and p=0.004, respectively).
A moderate-high correlation was found between the PESI score and the ATRIA and CHA2DS2-VASc scores (r=0.664, p<0.001, and
r=0.484, p<0.001) in the PE group. Pairwise comparison of ROC curve analysis revealed that PESI, ATRIA, and CHA2DS2-VASc scores
were not superior to each other in predicting mortality.
Conclusion: Both ATRIA and CHA2DS2-VASc scores are simple, easily calculated risk scores as an alternative to the PESI score in
predicting mortality in PE.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Bĕlohlávek J, Dytrych V, Linhart. A. Pulmonary embolism, part I: Epidemiology, risk factors and risk stratification, pathophysiology, clinical presentation, diagnosis and nonthrombotic pulmonary embolism. Exp Clin Cardiol 2013;18:129-38.
- 2. Marconi L, Carrozzi L, Aquilini F, Celi A, Pistelli F, Palla A. Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study. Medicine (Baltimore) 2016;95:e4364.
- 3. Altınsoy B, Erboy F, Tanrıverdi H, et al. Syncope as a presentation of acute pulmonary embolism. Ther Clin Risk Manag 2016;12:1023-8.
- 4. Ishaaya E, Tapson VF. Advances in the diagnosis of acute pulmonary embolism. F1000Res 2020;9:F1000 Faculty Rev-44.
- 5. Morrone D, Morrone V. Acute Pulmonary Embolism: Focus on the Clinical Picture. Korean Circ J 2018;48:365-81.
- 6. Chung HC, Lee CC, Lin YH. Clinical Manifestations and Prognostic Factors of Pulmonary Embolism in Adult Patients Visiting the Emergency Department: A Single Institute Experience. J Acute Med 2019;9:16-23.
- 7. Akyol PY, Karakaya Z, Topal FE, Payza U, Kaykısız EK. Simplified Pulmonary Embolism Severity Index in Predicting Mortality in Emergency Department. Konuralp Tıp Dergisi 2019;11:314-9.
- 8. Barnes GD, Muzikansky A, Cameron S, et al. Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams. JAMA Netw Open 2020;3:e2010779.
- 9. Penaloza A, Melot C, Motte S. Comparison of the Wells score with the simplified revised Geneva score for assessing pretest probability of pulmonary embolism. Thromb Res 2011;127:81-4.
- 10. Shen JH, Chen HL, Chen JR, Xing JL, Gu P, Zhu BF. Comparison of the Wells score with the revised Geneva score for assessing suspected pulmonary embolism: a systematic review and meta-analysis. J Thromb Thrombolysis 2016;41:482-92.
- 11. Piovella F, Iosub DI. Acute pulmonary embolism: risk assessment, risk stratification and treatment options. Clin Respir J 2016;10:545-54.
- 12. Zhou XY, Ben SQ, Chen HL, Ni SS. The prognostic value of pulmonary embolism severity index in acute pulmonary embolism: a meta-analysis. Respir Res 2012;13:111.
- 13. Essien EO, Rali P, Mathai SC. Pulmonary Embolism. Med Clin North Am 2019;103:549-64.
- 15. Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial fibrillation: the ATRIA study stroke risk score. J Am Heart Assoc 2013;2:e000250.
- 16. Kim TH, Yang PS, Uhm YS, et al. CHA2DS2-VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65-74, Female) for Stroke in Asian Patients With Atrial Fibrillation: A Korean Nationwide Sample Cohort Study. Stroke 2017;48:1524-30.
- 17. Yamamoto T. Management of patients with high-risk pulmonary embolism: a narrative review. J Intensive Care 2018;6:16.
- 18. Moorjani N, Price S. Massive pulmonary embolism. Cardiol Clin 2013;31:503-18.
- 19. Kürkciyan I, Meron G, Sterz F, et al. Pulmonary embolism as a cause of cardiac arrest: presentation and outcome. Arch Intern Med 2000;160:1529-35.
- 20. Sekhri V, Mehta N, Rawat N, Lehrman SG, Aronow WS. Management of massive and nonmassive pulmonary embolism. Arch Med Sci 2012;8:957-69.
- 21. Dabbouseh NM, Patel JJ, Bergl PA. Role of echocardiography in managing acute pulmonary embolism. Heart 2019;105:1785-92.
- 22. Sendama W, Musgrave KM. Decision-Making with D-Dimer in the Diagnosis of Pulmonary Embolism. Am J Med 2018;131:1438-43.
- 23. Hammons L, Filopei J, Steiger D, Bondarsky E. A narrative review of red blood cell distribution width as a marker for pulmonary embolism. J Thromb Thrombolysis 2019;48:638-47.
- 24. Giannitsis E, Katus HA. Biomarkers for Clinical Decision- Making in the Management of Pulmonary Embolism. Clin Chem 2017;63:91-100.
- 25. Wells P, Peacock WF, Fermann GJ, et al. The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis 2019;48:149-57.
- 26. Duman D, Sonkaya E, Yıldırım E, et al. Association of Inflammatory Markers with Mortality in Patients Hospitalized with Non-massive Pulmonary Embolism. Turk Thorac J 2021;22:24-30.
- 27. Wnag Q, Ma J, Jiang Z, Ming L. Prognostic value of neutrophil- to-lymphocyte ratio and platelet-to-lymphocyte ratio in acute pulmonary embolism: a systematic review and meta-analysis. Int Angiol 2018;37:4-11.
- 28. Angriman F, Ferreyro BL, Posadas-Martinez ML, Giunta D, Vazquez FJ, Vollmer WM. Wells Score and Poor Outcomes Among Adult Patients With Subsegmental Pulmonary Embolism: A Cohort Study. Clin Appl Thromb Hemost 2015;21:539-45.
- 29. Choi WC, Kwon SU, Jwa YJ, et al. The Pulmonary Embolism Severity Index in Predicting the Prognosis of Patients With Pulmonary Embolism. Korean J Intern Med 2009;24:123-7.
- 30. Gou DJ, Zhao C, Zou YD, Huang XH, Hu JM, Guo L.Values of the Wells and Revised Geneva Scores Combined with D-dimer in Diagnosing Elderly Pulmonary Embolism Patients. Chin Med J (Engl) 2015;128:1052-7.
- 31. Li X, Hu Y, Lin P, et al. Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer. Thromb Haemost 2021;121:834-44.
- 32. Girardi AM, Bettiol RS, Garcia TS, et al. Wells and Geneva Scores Are Not Reliable Predictors of Pulmonary Embolism in Critically Ill Patients: A Retrospective Study. J Intensive Care Med 2020;35:1112-7.
- 33. Gök M, Kurtul A, Harman M, Kara M, Süleymanoglu M, Ornek E. Relationship Between CHA2DS2-VASc Score and Right Ventricular Dysfunction in Patients With Acute Pulmonary Thromboembolism. Clin Appl Thromb Hemost 2018;24(Suppl 9):56S-62S.
- 34. Onuk T, Karataş MB, İpek G, et al. Higher CHA2DS2-VASc Score Is Associated With Increased Mortality in Acute Pulmonary Embolism. Clin Appl Thromb Hemost 2017;23:631-7.
- 35. Abacioglu OO, Yildirim A, Koyunsever NY, Kilic S. The ATRIA and Modified ATRIA Scores in Evaluating the Risk of No-Reflow in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention. Angiology 2021;73:79-84.
- 36. Zhu W, Wu Y, Zhou Y, et al. CHA2DS2-VASc and ATRIA Scores and Clinical Outcomes in Patients with Heart Failure with Preserved Ejection Fraction. Cardiovasc Drugs Ther 2020;34:763-72.
- 37. Öncel CR. Value of ATRIA risk score and gender in predicting adverse events in patients with myocardial infarction. Anatol J Cardiol 2018;20:370-1.
- 38. Aksoy F, Bagcı A. Predictive value of ATRIA risk score for contrast-induced nephropathy after percutaneous coronary intervention for ST-segment elevation myocardial infarction. Rev Assoc Med Bras (1992) 2019;65:1384-90.
| APA | Ozcan Abacioglu O, YİLDİRİM A, Karadeniz M, DİNDAŞ F, Abacıoğlu S, Yıldız Koyunsever N, DOGDUS M (2022). Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. , 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| Chicago | Ozcan Abacioglu Ozge,YİLDİRİM Arafat,Karadeniz Mine,DİNDAŞ FERHAT,Abacıoğlu Serkan,Yıldız Koyunsever Nermin,DOGDUS Mustafa Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. (2022): 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| MLA | Ozcan Abacioglu Ozge,YİLDİRİM Arafat,Karadeniz Mine,DİNDAŞ FERHAT,Abacıoğlu Serkan,Yıldız Koyunsever Nermin,DOGDUS Mustafa Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. , 2022, ss.145 - 151. 10.4274/haseki.galenos.2022.7783 |
| AMA | Ozcan Abacioglu O,YİLDİRİM A,Karadeniz M,DİNDAŞ F,Abacıoğlu S,Yıldız Koyunsever N,DOGDUS M Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. . 2022; 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| Vancouver | Ozcan Abacioglu O,YİLDİRİM A,Karadeniz M,DİNDAŞ F,Abacıoğlu S,Yıldız Koyunsever N,DOGDUS M Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. . 2022; 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| IEEE | Ozcan Abacioglu O,YİLDİRİM A,Karadeniz M,DİNDAŞ F,Abacıoğlu S,Yıldız Koyunsever N,DOGDUS M "Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism." , ss.145 - 151, 2022. 10.4274/haseki.galenos.2022.7783 |
| ISNAD | Ozcan Abacioglu, Ozge vd. "Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism". (2022), 145-151. https://doi.org/10.4274/haseki.galenos.2022.7783 |
| APA | Ozcan Abacioglu O, YİLDİRİM A, Karadeniz M, DİNDAŞ F, Abacıoğlu S, Yıldız Koyunsever N, DOGDUS M (2022). Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. Haseki Tıp Bülteni, 60(2), 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| Chicago | Ozcan Abacioglu Ozge,YİLDİRİM Arafat,Karadeniz Mine,DİNDAŞ FERHAT,Abacıoğlu Serkan,Yıldız Koyunsever Nermin,DOGDUS Mustafa Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. Haseki Tıp Bülteni 60, no.2 (2022): 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| MLA | Ozcan Abacioglu Ozge,YİLDİRİM Arafat,Karadeniz Mine,DİNDAŞ FERHAT,Abacıoğlu Serkan,Yıldız Koyunsever Nermin,DOGDUS Mustafa Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. Haseki Tıp Bülteni, vol.60, no.2, 2022, ss.145 - 151. 10.4274/haseki.galenos.2022.7783 |
| AMA | Ozcan Abacioglu O,YİLDİRİM A,Karadeniz M,DİNDAŞ F,Abacıoğlu S,Yıldız Koyunsever N,DOGDUS M Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. Haseki Tıp Bülteni. 2022; 60(2): 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| Vancouver | Ozcan Abacioglu O,YİLDİRİM A,Karadeniz M,DİNDAŞ F,Abacıoğlu S,Yıldız Koyunsever N,DOGDUS M Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism. Haseki Tıp Bülteni. 2022; 60(2): 145 - 151. 10.4274/haseki.galenos.2022.7783 |
| IEEE | Ozcan Abacioglu O,YİLDİRİM A,Karadeniz M,DİNDAŞ F,Abacıoğlu S,Yıldız Koyunsever N,DOGDUS M "Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism." Haseki Tıp Bülteni, 60, ss.145 - 151, 2022. 10.4274/haseki.galenos.2022.7783 |
| ISNAD | Ozcan Abacioglu, Ozge vd. "Evaluation of the ATRIA and CHA2DS2-VASc Scores and Their Performance on Predicting Mortality in Patients with Acute Pulmonary Embolism". Haseki Tıp Bülteni 60/2 (2022), 145-151. https://doi.org/10.4274/haseki.galenos.2022.7783 |
